STOCK TITAN

Arthur Torres (CDNA) files Form 144 to sell 4,200 shares of common stock

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Arthur Torres has filed a notice for the proposed sale of up to 4,200 shares of CDNA common stock through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares, with an aggregate market value of $200,475.24 as of 08/10/2026, were acquired as restricted stock from the issuer on 06/10/2026. Over the prior three months, Torres reported sales of 6,484 shares for $128,977.78 on 05/15/2026 and 4,086 shares for $85,697.72 on 05/14/2026.

Positive

  • None.

Negative

  • None.
Shares proposed for sale 4,200 shares Common stock covered by the notice through Morgan Stanley Smith Barney LLC
Aggregate market value $200,475.24 Value of 4,200 shares as of 08/10/2026
Prior sale 1 6,484 shares for $128,977.78 Common stock sale on 05/15/2026
Prior sale 2 4,086 shares for $85,697.72 Common stock sale on 05/14/2026
Acquisition date of shares 06/10/2026 Date restricted stock was acquired from issuer
Form 144 regulatory
"Arthur Torres has filed a notice for the proposed sale under Form 144"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock financial
"The shares were acquired as restricted stock from the issuer on 06/10/2026"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Securities To Be Sold regulatory
"144: Securities To Be Sold Common | 06/10/2026 | Restricted Stock"
Executive Financial Services financial
"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What CDNA shares does Arthur Torres plan to sell under Form 144?

Arthur Torres filed to sell up to 4,200 shares of CDNA common stock. The planned sale is through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated aggregate market value of $200,475.24 as of 08/10/2026.

At what value are Arthur Torres’s planned CDNA share sales recorded?

The planned sale of 4,200 CDNA shares is recorded at an aggregate market value of $200,475.24. This figure reflects the value as of 08/10/2026 in the Form 144 notice.

How and when did Arthur Torres acquire the CDNA shares to be sold?

The 4,200 CDNA shares covered by the notice were acquired as restricted stock from the issuer. The acquisition date listed is 06/10/2026, and the security type is identified as common stock.

What CDNA stock has Arthur Torres sold in the last 3 months before this notice?

Over the prior three months, Arthur Torres reported selling 6,484 shares of CDNA for $128,977.78 on 05/15/2026 and 4,086 shares for $85,697.72 on 05/14/2026, both in common stock.

Which broker is handling Arthur Torres’s planned CDNA stock sale?

The planned sale of 4,200 CDNA shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s address is 1 New York Plaza, 8th Floor, New York, NY 10004.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature